소아용 의료기기 시장 : 제품 유형, 휴대성, 재이용성, 동력원, 멸균 상태, 연령층, 최종사용자, 유통 채널별 - 시장 예측(2026-2032년)

The Pediatric Medical Device Market is projected to grow by USD 54.72 billion at a CAGR of 9.08% by 2032.

The pediatric medical device market is defined by technologies designed for neonates, infants, children, and adolescents whose anatomy, physiology, growth patterns, and care environments differ significantly from adults. Demand spans neonatal intensive care devices, pediatric respiratory care, infusion systems, monitoring platforms, surgical instruments, imaging accessories, orthopedic implants, cardiac devices, and connected home-care tools.

Market momentum is supported by measurable public health needs. UNICEF reports that the global child population exceeds 2 billion, while WHO identifies preterm birth complications, congenital anomalies, respiratory disease, infections, and injuries as major contributors to child morbidity and mortality. These realities reinforce the need for age-appropriate, safe, interoperable, and clinically validated pediatric healthcare technology that supports care across hospitals, clinics, emergency settings, and homes.

Transformative Shifts in the Pediatric Device Landscape

The landscape is shifting from adapting adult devices for children toward purpose-built pediatric medical devices with smaller form factors, lower dead-space volumes, child-friendly ergonomics, and usability features for caregivers. Hospitals are also prioritizing devices that support earlier diagnosis, minimally invasive care, remote monitoring, and shorter inpatient stays.

Regulation and procurement are becoming more evidence-driven. FDA pediatric device guidance, EU MDR clinical evidence expectations, ISO 13485 quality systems, ISO 14971 risk management, IEC 62304 software lifecycle controls, and healthcare cybersecurity expectations are raising the bar for product development. Manufacturers that integrate pediatric human factors, real-world evidence, post-market surveillance, and device interoperability into design strategy are better positioned for sustainable adoption.

Cumulative Impact of Artificial Intelligence in Pediatric Devices

Artificial intelligence is increasingly influencing pediatric medical devices through imaging support, neonatal monitoring, patient deterioration alerts, clinical decision support, workflow automation, and personalized therapy management. The FDA's public inventory of AI/ML-enabled medical devices shows rapid expansion of regulated AI across healthcare, with radiology and cardiology among the most active clinical areas relevant to pediatric care.

The cumulative impact of AI depends on pediatric-specific validation. Algorithms trained mainly on adult datasets can underperform in children because age, body size, disease presentation, and developmental stage affect data patterns. Industry leaders must prioritize representative datasets, bias testing, explainability, cybersecurity, human oversight, and lifecycle monitoring to ensure AI-enabled pediatric devices improve safety rather than introduce new clinical risk.

Key Regional Insights Across Global Pediatric Device Markets

North America remains a leading region for pediatric medical device innovation because of its concentration of children's hospitals, FDA regulatory pathways, clinical trial infrastructure, pediatric research networks, and reimbursement mechanisms. Europe shows strong demand for pediatric safety, traceability, and clinical evidence under EU MDR, while national health systems continue to emphasize value, interoperability, and cost-effective procurement across hospital and community care settings.

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in neonatal care, pediatric surgery, digital hospitals, and domestic medtech capacity. Latin America, led by Brazil and Mexico, is improving access to pediatric diagnostics and hospital equipment, although reimbursement and infrastructure gaps remain. The Middle East, especially GCC markets, is investing in specialty pediatric hospitals, connected care, and digital health platforms, while Africa presents long-term need for affordable neonatal, respiratory, infection-control, and point-of-care devices aligned with WHO child health priorities.

Key Group Insights for Pediatric Medical Device Growth

The G7 and European Union influence pediatric medical device standards through mature regulatory systems, public health funding, and strong clinical research networks. EU MDR has increased the importance of clinical evidence, post-market surveillance, unique device identification, and device traceability, while G7 markets remain central to innovation in connected monitoring, pediatric imaging, cardiac care, neonatal intensive care, and AI-enabled diagnostics.

BRICS countries represent a major demand base due to large child populations, expanding hospital infrastructure, and growing domestic manufacturing capacity, particularly in China, India, and Brazil. ASEAN markets are strengthening pediatric care through hospital modernization, immunization-linked health infrastructure, and regional health investment, although access varies by country. GCC countries are using healthcare diversification strategies to build specialty pediatric capacity, while NATO members increasingly emphasize secure medical supply chains, cybersecurity, resilience, and medical readiness for critical healthcare technologies.

Key Country Insights in Pediatric Medical Devices

The United States leads in pediatric medical device commercialization through FDA oversight, children's hospital networks, venture funding, academic research, and real-world evidence initiatives. Canada emphasizes safety, public reimbursement, health technology assessment, and equitable access, while Mexico benefits from proximity to North American manufacturing and rising private healthcare investment. Brazil is the largest Latin American opportunity, supported by specialist hospitals, public-private healthcare delivery, and demand for neonatal, respiratory, and diagnostic technologies.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced pediatric care with strong regulatory and reimbursement scrutiny, while Russia maintains demand for hospital-based pediatric equipment amid localized procurement dynamics. In Asia-Pacific, China and India offer scale and expanding pediatric infrastructure, Japan and South Korea contribute advanced engineering, imaging, robotics, and digital health capabilities, and Australia supports high-quality pediatric care through strong clinical governance, telehealth adoption, and connected medical technologies.

Actionable Recommendations for Pediatric Device Leaders

Industry leaders should prioritize pediatric-first design rather than resizing adult platforms. Successful products must address growth, anatomy, clinical workflow, caregiver usability, infection control, alarm fatigue, medication safety, biocompatibility, and long-term safety. Early collaboration with pediatric specialists, nurses, biomedical engineers, caregivers, and patient advocacy groups can improve adoption and reduce redesign risk.

Manufacturers should build evidence strategies that combine clinical studies, registries, real-world performance data, usability testing, and post-market surveillance. For AI-enabled pediatric medical devices, leaders should implement dataset governance, bias controls, model monitoring, cybersecurity, and transparent clinical validation. Commercial teams should also localize pricing, training, service models, regulatory submissions, and reimbursement evidence for each region.

Research Methodology and Evidence Foundation

This executive summary is based on a structured secondary research approach using publicly available evidence from regulatory agencies, public health organizations, standards bodies, peer-reviewed literature, hospital procurement trends, and recognized industry sources. Key references include guidance and public information from FDA, WHO, UNICEF, OECD, World Bank, European Commission resources, and international quality, software, usability, cybersecurity, and risk management standards.

Insights were synthesized through triangulation across disease burden, pediatric care delivery, regulatory requirements, technology adoption, reimbursement considerations, and regional healthcare investment patterns. The methodology emphasizes verified directional evidence over unsupported market claims, ensuring the analysis remains reliable for strategic planning, SEO-focused content, and executive decision-making.

Conclusion: Advancing Safer Pediatric Medical Technology

The pediatric medical device market is entering a period of disciplined innovation shaped by clinical need, regulatory rigor, digital transformation, and global access priorities. Demand is strongest for solutions that improve neonatal outcomes, support early diagnosis, enhance pediatric surgery, enable safe home care, and reduce preventable complications.

Organizations that combine pediatric-specific design, robust evidence generation, AI governance, resilient supply chains, and regional commercialization strategies will be best positioned to grow. The competitive advantage will belong to companies that can prove safety, usability, clinical value, interoperability, and affordability across diverse pediatric care environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pediatric Medical Device Market, by Product Type

• 7.1. Imaging Devices
  • 7.1.1. CT Scanners
  • 7.1.2. MRI Systems
  • 7.1.3. Ultrasound Systems
  • 7.1.4. Xray Systems
• 7.2. Infusion Therapy Devices
  • 7.2.1. Elastomeric Pumps
  • 7.2.2. Infusion Pumps
  • 7.2.3. Syringe Pumps
• 7.3. Monitoring Devices
  • 7.3.1. Cardiac Monitors
  • 7.3.2. Fetal Monitors
  • 7.3.3. Patient Monitors
  • 7.3.4. Respiratory Monitors
  • 7.3.5. Temperature Monitors
• 7.4. Respiratory Devices
  • 7.4.1. CPAP Devices
  • 7.4.2. Oxygen Concentrators
  • 7.4.3. Ventilators
• 7.5. Surgical Instruments
  • 7.5.1. Distractors & Retractors
  • 7.5.2. Endoscopes
  • 7.5.3. Scalpels And Forceps

8. Pediatric Medical Device Market, by Portability

• 8.1. Stationary
• 8.2. Handheld
• 8.3. Wearable

9. Pediatric Medical Device Market, by Reusability

• 9.1. Disposable
• 9.2. Reusable

10. Pediatric Medical Device Market, by Power Source

• 10.1. Manual
• 10.2. Battery Powered
• 10.3. Plug-In Electric
• 10.4. Hybrid Powered

11. Pediatric Medical Device Market, by Sterility

• 11.1. Sterile
• 11.2. Non-Sterile

12. Pediatric Medical Device Market, by Age Group

• 12.1. Adolescents
• 12.2. Child
• 12.3. Infants
• 12.4. Neonates

13. Pediatric Medical Device Market, by End User

• 13.1. Ambulatory Surgical Centers
• 13.2. Home Care Settings
• 13.3. Hospitals

14. Pediatric Medical Device Market, by Distribution Channel

• 14.1. Offline
• 14.2. Online

15. Pediatric Medical Device Market, by Region

• 15.1. Asia-Pacific
• 15.2. North America
• 15.3. Latin America
• 15.4. Europe
• 15.5. Middle East
• 15.6. Africa

16. Pediatric Medical Device Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Pediatric Medical Device Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025

19. Company Profiles

• 19.1. Abbott Laboratories
• 19.2. Atom Medical Corporation
• 19.3. B. Braun SE
• 19.4. Baxter International Inc.
• 19.5. Becton, Dickinson and Company
• 19.6. Boston Scientific Corporation
• 19.7. Cardinal Health, Inc.
• 19.8. Cook Group Incorporated
• 19.9. Dragerwerk AG & Co. KGaA
• 19.10. Edwards Lifesciences Corporation
• 19.11. Fritz Stephan GmbH
• 19.12. GE HealthCare Technologies Inc.
• 19.13. Getinge AB
• 19.14. Hamilton Medical AG
• 19.15. Hill-Rom Holdings, Inc.
• 19.16. Hologic, Inc.
• 19.17. Koninklijke Philips N.V.
• 19.18. Masimo Corporation
• 19.19. Medtronic plc
• 19.20. Mindray Medical International Limited
• 19.21. Natus Medical Incorporated
• 19.22. Nipro Corporation
• 19.23. OrthoPediatrics Corp.
• 19.24. Siemens Healthineers AG
• 19.25. Smith & Nephew plc
• 19.26. Smiths Group plc
• 19.27. Stryker Corporation
• 19.28. Teleflex Incorporated
• 19.29. Terumo Corporation
• 19.30. TSE Medical